Theravance Biopharma Inc (TBPH)
9.60
-0.13
(-1.34%)
USD |
NASDAQ |
Dec 20, 16:00
9.45
-0.15
(-1.56%)
After-Hours: 20:00
Theravance Biopharma Shareholders Equity (Quarterly): 185.65M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 638.84M |
| Madrigal Pharmaceuticals Inc | 777.16M |
| Ionis Pharmaceuticals Inc | 662.47M |
| Jazz Pharmaceuticals PLC | 4.171B |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 356.10M |
| Total Liabilities (Quarterly) | 170.45M |
| Current Ratio | 4.970 |